Literature DB >> 23736925

Antiplatelet agents in clinical practice and their haemorrhagic risk.

Paolo Gresele1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23736925      PMCID： PMC3729124          DOI： 10.2450/2013.0248-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  58 in total

Review 1.  Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

Authors:  C Patrono; B Coller; J E Dalen; G A FitzGerald; V Fuster; M Gent; J Hirsh; G Roth
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Novel approaches to the treatment of thrombosis.

Authors:  Paolo Gresele; Giancarlo Agnelli
Journal:  Trends Pharmacol Sci       Date:  2002-01       Impact factor: 14.819

3.  Vorapaxar in the secondary prevention of atherothrombotic events.

Authors:  David A Morrow; Eugene Braunwald; Marc P Bonaca; Sebastian F Ameriso; Anthony J Dalby; Mary Polly Fish; Keith A A Fox; Leslie J Lipka; Xuan Liu; José Carlos Nicolau; A J Oude Ophuis; Ernesto Paolasso; Benjamin M Scirica; Jindrich Spinar; Pierre Theroux; Stephen D Wiviott; John Strony; Sabina A Murphy
Journal:  N Engl J Med       Date:  2012-03-24       Impact factor: 91.245

Review 4.  Inhibitors of the interaction between von Willebrand factor and platelet GPIb/IX/V.

Authors:  Paolo Gresele; Stefania Momi
Journal:  Handb Exp Pharmacol       Date:  2012

5.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

6.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

7.  The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial.

Authors:  Nancy M Heddle; Richard J Cook; Donald M Arnold; Mark A Crowther; Theodore E Warkentin; Kathryn E Webert; Jack Hirsh; Rebecca L Barty; Yang Liu; Connie Lester; John W Eikelboom
Journal:  Transfusion       Date:  2012-01-18       Impact factor: 3.157

8.  Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs.

Authors:  Stefania Momi; Michela Tantucci; Maarten Van Roy; Hans Ulrichts; Giovanni Ricci; Paolo Gresele
Journal:  Blood       Date:  2013-04-15       Impact factor: 22.113

Review 9.  Intracellular signaling as a potential target for antiplatelet therapy.

Authors:  Patrick Andre
Journal:  Handb Exp Pharmacol       Date:  2012

Review 10.  PAR-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with atherothrombosis.

Authors:  Sergio Leonardi; Richard C Becker
Journal:  Handb Exp Pharmacol       Date:  2012
View more
  2 in total

1.  Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome.

Authors:  Giuseppe Patti; Ilaria Cavallari; Emilia Antonucci; Paolo Calabrò; Plinio Cirillo; Paolo Gresele; Gualtiero Palareti; Vittorio Pengo; Pasquale Pignatelli; Elisabetta Ricottini; Rossella Marcucci
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

2.  The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential.

Authors:  María N Barrachina; Irene Izquierdo; Lidia Hermida-Nogueira; Luis A Morán; Amparo Pérez; Ana B Arroyo; Nuria García-Barberá; Rocío González-Conejero; Sara Troitiño; Johannes A Eble; José Rivera; Constantino Martínez; María I Loza; Eduardo Domínguez; Ángel García
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.